期刊文献+

炎症因子与胰岛素抵抗及糖尿病亚临床血管病变的关系研究 被引量:8

The Correlations between Inflammatory Factors,Insulin Resistance and Diabetic Sub-clinical Vascular Disease
暂未订购
导出
摘要 目的探讨血清脂联素、瘦素、肿瘤坏死因子-α(TNF-α)与2型糖尿病(T2DM)患者胰岛素抵抗及亚临床血管病变的相关性。方法选择199例T2DM患者,根据颈动脉内膜中层厚度(IMT)将患者分为两组:IMT≥0.9mm者作为亚临床血管病变组(A组,110例),IMT<0.9mm者作为无血管病变组(B组,89例)。检测两组患者血清脂联素、瘦素、TNF-α水平,计算胰岛素抵抗指数(HOMA-IR)。分析脂联素、瘦素及TNF-α与HO-MA-IR、IMT的关系。结果 A组患者血清脂联素水平〔(2.76±1.25)mmol/L〕显著低于B组〔(3.06±1.40)mmol/L〕,而瘦素水平〔(0.85±0.44)mmol/L〕显著高于B组〔(0.62±0.36)mmol/L〕,差异有统计学意义(P<0.05);而TNF-α水平〔分别为(0.44±0.13)pg/ml和(0.38±0.12)pg/ml〕间差异无统计学意义(P>0.05)。脂联素与HOMA-IR、IMT呈负相关(P<0.05),瘦素与HOMA-IR、IMT呈正相关(P<0.05),TNF-α仅与IMT呈正相关(P<0.05)。结论脂联素可能是T2DM患者胰岛素抵抗及亚临床血管病变的保护因子,瘦素可能是二者的危险因子,而TNF-α与胰岛素抵抗无明显相关性。 Objective To explore the correlations between serum adiponectin (APN),leptin (LEP),tumor necrosis factor-α (TNF-α),insulin resistance and sub-clinical vascular disease in type 2 diabetic patients.Methods 199 patients with type 2 diabetes mellitus were selected,they are divided into two groups according to the carotid intima-media thickness (IMT):sub-clinical vascular disease group,which includes patients whose IMT≥0.9 mm (A group,110 examples),the other was non-clinical vascular disease group,which includes patients whose IMT0.9 mm (B group,89 examples).Test the levels of APN,LEP and TNF-α,calculate the insulin resistance index (HOMA-IR),and analyze the correlations between APN,LEP,TNF-α,HOMA-IR and IMT.Results The level of APN in group A〔(2.76±1.25)mmol/L〕 was significantly lower than that in group B〔(3.06±1.40)mmol/L〕,while the level of LEP in group A〔(0.85±0.44)mmol/L〕 was significantly higher than that group B〔(0.62±0.36)mmol/L〕,there were significant differences between the two groups (P0.05).But there was no significant differences between the level of TNF-αin group A〔(0.44±0.13)pg/ml〕 and group B〔(0.38±0.12)pg/ml〕(P0.05).APN was negatively correlated to HOMA-IR and IMT (P0.05),LEP was positively correlated to HOMA-IR and IMT (P0.05),but TNF-α was only positively correlated to IMT(P0.05).Conclusion APN may be the protective factor of insulin resistance and sub-clinical vascular disease in T2CM patients,while LEP may be the risk factor,but TNF-α was not significantly related to insulin resistance.
出处 《中国全科医学》 CAS CSCD 北大核心 2010年第26期2900-2902,2905,共4页 Chinese General Practice
关键词 脂联素 瘦素 肿瘤坏死因子Α 胰岛素抵抗 亚临床血管病变 Adiponectin Leptin Tumor necrosis factor-alpha Insulin resistance Sub-clinical vascular disease
  • 相关文献

参考文献19

  • 1Pradhan AD,Ridker PM.Do atherosclerosis and type 2 diabetes share a common inflammatory basis?[J].Eur Heart J,2002,23(11):831-834.
  • 2Ziegler D.Type 2 diabetes as an inflammatory cardiovascular disorder[J].Curr Mol Med,2005,5(3):309-322.
  • 3Sunsaneevithayakul P,Boriboohirunsarn D,Sutanthavibul A,et al.Risk factor-based selective screening program for gestational diabetes mellitus in Siriraj Hospital:result from clinical practice guideline[J].J Med Assoc Thai,2003,86(8):708-714.
  • 4潘志兰,邢英杰,聂丽敏,阮琳,张国欣.2型糖尿病患者大血管病变相关因素分析[J].疑难病杂志,2009,8(9):532-534. 被引量:10
  • 5李桂平,李延兵,彭娜,李绪娴,钟思干,曾荣辉.阿托伐他汀对2型糖尿病患者血清脂联素水平及颈动脉内膜中层厚度的影响[J].疑难病杂志,2009,8(6):335-337. 被引量:19
  • 6劳力敏,向红丁.脂联素基因多态性与妊娠糖尿病的相关性[J].中国全科医学,2008,11(18):1640-1642. 被引量:14
  • 7顾卫琼,陈名道,顾元骏,唐金凤,孙首悦,刘长勤,洪洁,张翼飞,李小英,宁光.脂联素受体在胰岛细胞表达,脂联素促进胰岛素的分泌[J].中华内分泌代谢杂志,2005,21(1):68-70. 被引量:34
  • 8Snijder MB,Heine RJ,Seidell JC,et al.Associations of adiponectin levels with incident impaired glucose metabolism and type 2 diabetes in older men and women:the hoorn study[J].Diabetes Care,2006,29(11):2498-2503.
  • 9Dullaart RP,de Viets R,von Tol A,et al.Lower plasma adiponectin is a marker of increased intima-media thickness associated with type 2 diabetes mellitus and with male gender[J].Eur J Endocrinol,2007,156(3):387-394.
  • 10Maeda N,Shimomura I,Kishida K,et al.Diet-induced insulin resistance in mice lacking adiponectin/ACRP30[J].Nat Med,2002,8(7):731-737.

二级参考文献67

共引文献123

同被引文献84

  • 1肖新华.胰岛素抵抗的病理生理机制和治疗选择[J].国外医学(内分泌学分册),2005,25(3):179-181. 被引量:19
  • 2Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..非酒精性脂肪性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):161-163. 被引量:1516
  • 3李伟,向红丁,戴为信,萧新华,夏维波,伍学焱,冯凯.2型糖尿病患者非酒精性脂肪肝及其相关因素的临床分析[J].中国糖尿病杂志,2006,14(1):35-36. 被引量:23
  • 4陆再英,钟南山.内科学[M].7版.北京:人民卫生出版社,2008:382.
  • 5Carlesson M,Wessman Y,Almgren P,et al.High levels of nonesterfied fattyacids are associated with increased familial risk of cardiovascular disease[J].Arterioscler Throm Vasc Biol,2000,20:1588-1594.
  • 6Trovati M,Anfossi G.Influence of insulin and of insulin resistance on platelet and vascular smooth muscle cell function[J].J Diabetes Complications,2002,16(1):35-40.
  • 7Ferreira IA,Mocking AI,Feijge MA,et al.Platelet inhibition by insulin is absent in type 2 diabetes mellitus[J].Arterioscler Thromb Vasc Biol,2006,26 (2):417-422.
  • 8Dezaki K, Kakei M, Yada T. Ghrelin uses Ga i2 and activates voltage - dependent K + channels to attenuate glucose - induced Ca2 + signaling and insulin release in islet beta - ceils : novel signal transduction of gh- relin [J]. Diabetes, 2007, 56 (9): 2319-2327.
  • 9Kojima M, Hosoda H, Date Y, et al. Ghrelin is a growth - hormone - releasing acylated peptide from stomach [ J 1. Nature, 1999, 402 (6762) : 656 -660.
  • 10Poykko SM, Kellokoski E, Horkko S, et al. Low plasma ghrelin is as- sociated with insulin resistance, hypertension, and the prevalence of type2 diabetes [J]. Diabetes, 2003, 52 (10): 2546-2553.

引证文献8

二级引证文献81

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部